Beneficial effects of a mouthwash containing an antiviral phthalocyanine derivative on the length of hospital stay for COVID-19: randomised trial.

MLA

da Silva Santos, Paulo Sérgio, et al. “Beneficial Effects of a Mouthwash Containing an Antiviral Phthalocyanine Derivative on the Length of Hospital Stay for COVID-19: Randomised Trial.” Scientific Reports, vol. 11, no. 1, Oct. 2021, p. 19937. EBSCOhost, https://doi.org/10.1038/s41598-021-99013-5.

APA

da Silva Santos, P. S., da Fonseca Orcina, B., Machado, R. R. G., Vilhena, F. V., da Costa Alves, L. M., Zangrando, M. S. R., de Oliveira, R. C., Soares, M. Q. S., Simão, A. N. C., Pietro, E. C. I. N., Kuroda, J. P. G., de Almeida Benjamim, I. A., Araujo, D. B., Toma, S. H., Flor, L., Araki, K., & Durigon, E. L. (2021). Beneficial effects of a mouthwash containing an antiviral phthalocyanine derivative on the length of hospital stay for COVID-19: randomised trial. Scientific Reports, 11(1), 19937. https://doi.org/10.1038/s41598-021-99013-5

Chicago

da Silva Santos, Paulo Sérgio, Bernardo da Fonseca Orcina, Rafael Rahal Guaragna Machado, Fabiano Vieira Vilhena, Lucas Marques da Costa Alves, Mariana Schutzer Ragghianti Zangrando, Rodrigo Cardoso de Oliveira, et al. 2021. “Beneficial Effects of a Mouthwash Containing an Antiviral Phthalocyanine Derivative on the Length of Hospital Stay for COVID-19: Randomised Trial.” Scientific Reports 11 (1): 19937. doi:10.1038/s41598-021-99013-5.